Skip to content

Development of a New Method for Liver Stiffness Measurement Using FibroScan

M148 - Development of a New Method for Liver Stiffness Measurement Using FibroScan

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06519331
Acronym
M148
Enrollment
153
Registered
2024-07-25
Start date
2024-11-08
Completion date
2027-12-01
Last updated
2026-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Diseases

Keywords

FibroScan, Vibration Controlled Transient Elastography, Liver Stiffness Measurement

Brief summary

This is an European, prospective, interventional, multicenter clinical investigation that will take place in 2 French sites. 153 adults patients will be included. The study objective is to develop a new method for measuring liver stiffness using FibroScan.

Interventions

Patients #1 to #25: Exam 1: Examination with Research FibroScan. Exam 2: Examination with the Reference FibroScan at the same measurement point and with the same probe used for the Exam 1. Patients #26 to #75: Exam 1: Examination with the Research or Reference FibroScan. Exam 2: Examination with the Reference or Research FibroScan at the same measurement point and with the same probe used for the Exam 1. Patients #76 to #114: Exams 1 \& 2: 2 consecutive examinations with the Research or Reference FibroScan. Exams 3 \& 4: 2 consecutive examinations with the Reference or Research FibroScan at the same measurement point and with the same probe used for the Exams 1 \& 2.

Sponsors

Echosens
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients (≥ 18 years of age) followed in the hepatology or endocrinology department for liver disease, suspected liver disease or consequences of liver disease, all etiologies combined. * Adult patient able to give his written consent * Patient affiliated to the French Social Security system

Exclusion criteria

* Vulnerable patients * Patients with liver ascites * Patients with heart failure

Design outcomes

Primary

MeasureTime frame
Reduced intra-examination dispersion of liver stiffness measurements with the new measurement method.24 months

Secondary

MeasureTime frameDescription
Bias between the different stiffness measurements (reference/estimated reference/at rest)24 monthsCorrelation coefficients will be done.
Bias between the estimated reference stiffness repetitions and between the stiffness at rest repetitions.24 monthsIntra-class correlation coefficients will be done.
Bias between the CAP measured with the Research FibroScan and the CAP measured with the Reference FibroScan24 monthsCorrelation coefficients will be done.
Bias between the CAP repetitions done with the Research FibroScan24 monthsIntra-class correlation coefficients will be done.

Countries

France

Contacts

CONTACTAnne Llorca
anne.llorca@echosens.com+33144827850
CONTACTLaura Cantu-Sanchez
laura.cantusanchez@echosens.com+33144827850

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 6, 2026